These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8427038)
1. Evaluation of vaccines and of antigen therapy in a mouse model for Brucella ovis. Jiménez de Bagüés MP; Marín CM; Barberán M; Blasco JM Vaccine; 1993; 11(1):61-6. PubMed ID: 8427038 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams. Blasco JM; Gamazo C; Winter AJ; Jiménez de Bagüés MP; Marín C; Barberán M; Moriyón I; Alonso-Urmeneta B; Díaz R Vet Immunol Immunopathol; 1993 Aug; 37(3-4):257-70. PubMed ID: 8236802 [TBL] [Abstract][Full Text] [Related]
3. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis. Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618 [TBL] [Abstract][Full Text] [Related]
4. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4. Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881 [TBL] [Abstract][Full Text] [Related]
5. Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams. Muñoz PM; Estevan M; Marín CM; Jesús De Miguel M; Jesús Grilló M; Barberán M; Irache JM; Blasco JM; Gamazo C Vaccine; 2006 Mar; 24(11):1897-905. PubMed ID: 16337315 [TBL] [Abstract][Full Text] [Related]
6. Brucella species lacking the major outer membrane protein Omp25 are attenuated in mice and protect against Brucella melitensis and Brucella ovis. Edmonds MD; Cloeckaert A; Elzer PH Vet Microbiol; 2002 Sep; 88(3):205-21. PubMed ID: 12151196 [TBL] [Abstract][Full Text] [Related]
7. Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines. Jiménez de Bagüés MP; Elzer PH; Blasco JM; Marín CM; Gamazo C; Winter AJ Infect Immun; 1994 Feb; 62(2):632-8. PubMed ID: 8300219 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy of Brucella suis strain 2 and Brucella melitensis Rev. 1 live vaccines against a Brucella melitensis experimental infection in pregnant ewes. Verger JM; Grayon M; Zundel E; Lechopier P; Olivier-Bernardin V Vaccine; 1995 Feb; 13(2):191-6. PubMed ID: 7625115 [TBL] [Abstract][Full Text] [Related]
9. Evaluation in mice of Brucella ovis attenuated mutants for use as live vaccines against B. ovis infection. Sancho P; Tejedor C; Sidhu-Muñoz RS; Fernández-Lago L; Vizcaíno N Vet Res; 2014 Jun; 45(1):61. PubMed ID: 24898325 [TBL] [Abstract][Full Text] [Related]
10. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection. Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections. Adone R; Francia M; Ciuchini F Vaccine; 2008 Sep; 26(38):4913-7. PubMed ID: 18675869 [TBL] [Abstract][Full Text] [Related]
12. Protection Provided by an Encapsulated Live Attenuated ΔabcBA Strain of Brucella ovis against Experimental Challenge in a Murine Model. Silva AP; Macêdo AA; Silva TM; Ximenes LC; Brandão HM; Paixão TA; Santos RL Clin Vaccine Immunol; 2015 Jul; 22(7):789-97. PubMed ID: 25947146 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of Brucella melitensis Rev. 1 vaccine against Brucella ovis infection in rams. Fensterbank R; Pardon P; Marly J Ann Rech Vet; 1982; 13(2):185-90. PubMed ID: 7168540 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of Brucella suis strain 2 vaccine against Brucella ovis in rams. Blasco JM; Marín C; Jiménez de Bagüés MP; Barberán M Vaccine; 1993 Oct; 11(13):1291-4. PubMed ID: 8296481 [TBL] [Abstract][Full Text] [Related]
15. Experiments on a sub-unit vaccine encapsulated in microparticles and its efficacy against Brucella melitensis in mice. Estevan M; Gamazo C; Grilló MJ; Del Barrio GG; Blasco JM; Irache JM Vaccine; 2006 May; 24(19):4179-87. PubMed ID: 16481077 [TBL] [Abstract][Full Text] [Related]
16. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination. Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA Vaccine; 2007 May; 25(22):4437-46. PubMed ID: 17442465 [TBL] [Abstract][Full Text] [Related]
17. Immunization against Brucella infections. Priming of Cynomolgus philipinensis with purified antigen of Brucella melitensis prior to injection of Rev. I vaccine. Chen TH; Elberg SS J Comp Pathol; 1973 Jul; 83(3):357-67. PubMed ID: 4199459 [No Abstract] [Full Text] [Related]
18. A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response. Cassataro J; Velikovsky CA; de la Barrera S; Estein SM; Bruno L; Bowden R; Pasquevich KA; Fossati CA; Giambartolomei GH Infect Immun; 2005 Oct; 73(10):6537-46. PubMed ID: 16177328 [TBL] [Abstract][Full Text] [Related]
19. The Brucella abortus RB51 vaccine does not confer protection against Brucella ovis in rams. Jiménez de Bagüés MP; Barberán M; Marín CM; Blasco JM Vaccine; 1995 Feb; 13(3):301-4. PubMed ID: 7631517 [TBL] [Abstract][Full Text] [Related]
20. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep. Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]